AGBL West Africa has announced the successful installation of a new DNA Flow hybridization system at the Center De Recherche Biomoleculaire Pietro Annigoni (CERBA) in Burkina Faso.
“Alliance Global has played an essential role in the development of the Center, which has become a reference center in West Africa. We believe that this system will help them greatly with the design and automation of in vitro molecular tests (HPV genotyping, sepsis, AMR, STD, Respiratory Viruses and Zoonosis diagnosis) where quick sensitive and specific results are required,” said Mr. Mohamed Ben Marzouk, a senior Area Manager at AGBL Afrique.
Dr. Albert Theophane YONLI, Vice-Director of CERBA, emphasized, “I would like to thank Alliance Global for keeping us up to date with the new technologies and helping us improving the healthcare system in Burkina Faso and the region.”
-Ends-
About AGBL West Africa
AGBL West Africa is a member of the AGBL group of companies, the largest biomedical distribution group in the Middle East, Africa, and Asia region. The group is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic centres in emerging healthcare markets. AGBL West Africa is headquartered in Accra, Ghana, with branches and field staff across Nigeria and West Africa.
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
